Company Analysis

CollPlant Biotechnologies Ltd (CLGN)

Nasdaq: CLGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, IL · filing with the SEC since 2015
Grade5.1
◀ Past 4.9● Present 4.4▶ Future 6.4
2 est.

Who runs CollPlant Biotechnologies Ltd

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rotem Eran
Deputy CEO and CFO. First filing Mar 2026, latest Sep 8, 2026, 0 filings in all.
Officers reporting now
7
of 11 people with a filing in the last fifteen months
Directors reporting now
4
11 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rotem EranDeputy CEO and CFOMar 2026Sep 8, 2026none
Abelis Bar BertaVP LegalMar 2026Sep 8, 2026none
Tal YehielChief Executive OfficerMar 2026Mar 19, 2026none
Bagley BowmanVP Commercial North AmericaMar 2026Mar 18, 2026none
Bensimon PhilippeVP Regulations and QAMar 2026Mar 18, 2026none
Fahimipoor OrenVP OperationsMar 2026Mar 18, 2026none
Seror JasmineVP Product DevelopmentMar 2026Mar 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Evans Hugh MdirectorApr 2026Apr 27, 2026none
Havron AvrahamdirectorMar 2026Mar 18, 2026none
Lask AlisadirectorMar 2026Mar 18, 2026none
Penn ElandirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CLGN · research, not advice